Essential Medicines

as defined by the World Health Organization, refers to those medicines that, “… satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, evidence on efficacy and safety, and comparative cost-effectiveness. Essential medicines are intended to be available within the context of functioning health systems at all times in adequate amounts, in the appropriate dosage forms, with assured quality and adequate information, and at a price the individual and the community can afford. The implementation of the concept of essential medicines is intended to be flexible and adaptable to many different situations; exactly which medicines are regarded as essential remains a national responsibility.” http://www.who.int/topics/essential_medicines/en/

  1. International Narcotics Control Board. 1961 Single Convention on Narcotic Drugs: Part 1: The International Control System for Narcotic Drugs. Vienna, Austria: International Narcotics Control Board, 2005. (Available at http://www.incb.org/pdf/e/estim/trainmat/NAR_1%20English%202005.pdf).
  2. World Health Organization. Achieving balance in national opioids control policy: Guidelines for assessment. Geneva, Switzerland: World Health Organization, 2000. (Available at http://www.painpolicy.wisc.edu/publicat/00whoabi/00whoabi.htm).
  3. Morgan JP. American opiophobia: Customary underutilization of opioid analgesics. In: Hill CS, Fields WS, eds. Advances in Pain Research and Therapy, Volume 11. vol. 11. New York, NY: Raven Press, 1989:181-189. 
  4. Bennett DS, Carr DB. Opiophobia as a barrier to the treatment of pain. J Pain Palliat Care Pharmacother 2002;16:105-109.
  5. International Association for the Study of Pain. International Association for the Study of Pain Web site. http://www.iasp-pain.org/AM/Template.cfm?Section=General_Resource_Links&Template=/CM/HTMLDisplay.cfm&ContentID=3058
  6. World Health Organization. National cancer control programmes: policies and managerial guidelines. Second ed. Geneva, Switzerland: World Health Organization, 2002. (Available at http://www.who.int/cancer/nccp/nccp/en/).
  7. Controlled Substances Act, 812, Schedules of controlled substances. 
  8. District Court of Appeal of Florida, Third District.676 So.2d 1380, June 26, 1996.
  9. World Health Organization. WHO expert committee on drug dependence: thirty-fourth report. Geneva, Switzerland: World Health Organization, 2006. (Available at http://www.who.int/medicines/areas/quality_safety/WHO_TRS_942.pdf)

Note: Some of these are in Adobe Acrobat format (*.pdf), and will automatically download when you select it at the INCB website.  To read it, download a free copy of the Adobe Acrobat Reader.